Jeff Ervin

Jeff Ervin is an accomplished finance professional with extensive experience in executive leadership and financial management across various sectors. Currently serving as the Chief Financial Officer at Allarity Therapeutics since July 2025, Ervin also holds a position on the Board of Directors at Cingulate Inc. since February 2024. Previously, Ervin acted as Co-Chief Financial Officer at DayDayCook from June 2024 to February 2025 and was the Chief Executive Officer at IMAC Holdings from February 2015 to May 2024. Ervin's earlier roles include Vice President of Finance and Corporate Development at Medx Publishing and positions in finance at BH1. Academic qualifications include an MBA in Finance and Strategy from Vanderbilt University, corporate strategy studies from Stanford University, and a Bachelor of Science in Finance from Miami University.